ArticleCancer biology & therapy2020

DBDx-based drug combinations show highly potent therapeutic efficacy against human pancreatic cancer xenografts in athymic mice.

Yan-Bo Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.